Table 3 Baseline patient complications by geographical region
All | China | South Asia | East Asia | North Africa | Middle East | Latin America | Russia | |
|---|---|---|---|---|---|---|---|---|
Patients with macrovascular complications, n (%) | 17,806 (27.2) | 2,342 (21.3) | 4,946 (23.3) | 2,685 (26.8) | 979 (24.2) | 4,293 (28.7) | 335 (29.4) | 2,226 (72.4) |
Patients with microvascular complications, n (%) | 35,078 (53.5) | 5,467 (49.6) | 8,293 (39.0) | 5,615 (56.0) | 2,397 (59.4) | 9,847 (65.8) | 715 (62.8) | 2,744 (89.3) |
Renal disease, n (%) | 18,271 (27.9) | 2,455 (22.3) | 4,321 (20.3) | 2,845 (28.4) | 1,077 (26.7) | 6,108 (40.8) | 376 (33.0) | 1,089 (35.4) |
Eye problems, n (%) | 17,198 (26.3) | 2,430 (22.1) | 3,464 (16.3) | 2,380 (23.7) | 1,354 (33.5) | 5,081 (33.9) | 368 (32.3) | 2,121 (69.0) |
Foot ulcer, n (%) | 3,538 (5.4) | 274 (2.5) | 1,046 (4.9) | 536 (5.3) | 147 (3.6) | 1,289 (8.6) | 85 (7.5) | 161 (5.2) |
Neuropathy, n (%) | 25,179 (38.4) | 3,671 (33.3) | 5,234 (24.6) | 3,706 (36.9) | 1,530 (37.9) | 7,995 (53.4) | 491 (43.1) | 2,552 (83.0) |